Renton Hollings
- SEC CIK
- 0001187333
No open-market purchases or sales filed in the past year.
Current role at each company
- ANAB Anaptysbio, IncDirectoras of Jun 17, 2026
- ZYME Zymeworks Inc.Directoras of Dec 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Renton Hollings as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ANAB Anaptysbio, Inc
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 (view filing) | Aug 8 | 4 days | Renton HollingsDirector | SSale | −10.2K | $19.62 | −$200.7K | −67.3%4.96K after | 2 lots10b5-1 |
| Jul 3, 2025 (view filing) | Jul 2 | 1 day | Renton HollingsDirector | SSale | −20.9K | $23.57 | −$493.1K | −80.8%4.96K after | 2 lots10b5-1 |
| Jun 20, 2025 (view filing) | Jun 18 | 2 days | Renton HollingsDirector | SSale | −3.02K | $23.97 | −$72.3K | −37.8%4.96K after | 10b5-1 |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Renton HollingsDirector | SSale | −10.0K | $25.00 | −$250.0K | −83.7%1.95K after | 10b5-1 |
| Jul 17, 2024 (view filing) | Jul 15 | 2 days | Renton HollingsDirector | SSale | −10.0K | $30.64 | −$306.4K | −83.7%1.95K after | 2 lots10b5-1 |
| Jun 18, 2024 (view filing) | Jun 18 | Same day | Renton HollingsDirector | SSale | −1.95K | $23.16 | −$45.2K | −50.0%1.95K after |